This study identified that PROSTest demonstrated high diagnostic accuracy (>90%) and reproducibility in risk stratification for PCa among men with PSA ≥ 3 ng/mL, independent of DRE findings or PSA levels. Here, KLK3 is linked to posterior cortical atrophy.